Why Intersect ENT is an Example of Hope for the Medtech Industry

Medsider Radio: Learn from Medical Device and Medtech Thought Leaders

Content provided by Scott Nelson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Scott Nelson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

11y ago

MP3•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on July 14, 2019 01:41 (5y ago). Last successful fetch was on June 12, 2019 01:23 (5y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

The 2.3% medical device tax is burdensome. Regulatory timelines are long (and expensive). Reimbursement is not only decreasing, but also incredibly hard to obtain. Venture capitalists are losing interest in early stage medical device deals. Is it all downhill for medtech?

There is no doubt the current healthcare environment is challenging. But certainly not impossible!

Case in point: Intersect ENT. This startup medtech company is well-funded as evidenced by their recent series C round of...

Read more... »

31 episodes

#Business #Medical Device #Medtech #Biotech #Pharma #Digital Health #Mobile Health #Healthcare #FDA #Reimbursement #Regulatory #Sales #Marketing #PMA #510k